Home » Freeman Technology to Co-Sponsor Pharma Manufacturing Course
Freeman Technology to Co-Sponsor Pharma Manufacturing Course
Freeman Technology and Gericke, Glatt and K-Tron will sponsor a three-day course organized by Mixing Consultants, which is designed for pharmaceutical manufacturing professionals. Featuring a new program delivered by academic experts from Rutgers University and recognized industry leaders, "Design and Implementation of Continuous Pharmaceutical Manufacturing Processes" runs in Bethesda, MD, (USA) Nov. 28-30, 2012, and in Zurich, Switzerland, Dec. 12-14, 2012.
Professor Fernando Muzzio, Director of the Engineering Research Center on Structured Organic Particulate Systems at Rutgers University leads the course. He and fellow presenters take participants through Fundamentals on Day 1, Integrated Design and Mechanical Integration on Day 2, and finish with Modeling and Control on Day 3.
Tim Freeman, Managing Director of Freeman Technology, will present a session on "Measuring and Understanding Powder Flow."
“I’ve been teaching on Mixing Consultants courses for a number of years now and they are always stimulating events that I am very pleased to be associated with,” Freeman said. “As well as the formal sessions, there is plenty of opportunity for participants to spend time with--and really learn from--the presenters and course leaders, and to tap into their considerable experience and expertise. I’m looking forward to well attended sessions and lively discussion as always.”
Full details of the course program, fees and how to register are available at http://www.freemantech.co.uk/en/news-and-events/events.html.
Merck Stops Development of Parkinsonís DrugFrom Bloomberg
Merck & Co. will end development of preladenant because a preliminary review of late-stage clinical trials suggests it doesnít work
French Drugmaker on Trial for Suspected DeathsFrom Yahoo! News
Servier Laboratories, French drugmaker responsible for producing diabetes and weight loss drug Mediator, faces charges for deception in relation to the suspected deaths of hundreds of people.
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
- All news »